Use of Ultrasound in the Initial Management of Patients in Shock in the Nancy Emergency Department

Use of Ultrasound in the Initial Management of Patients in Shock in the Nancy Emergency Department - Retrospective Descriptive Analysis

Context: shock is a serious pathology where diagnostic and therapeutic speed determines the prognosis, ultrasound can be a valuable aid for the emergency physician to differentiate the different types of shock and allow appropriate treatment.

Hypothesis: what are the uses of ultrasound in the initial diagnostic and therapeutic management of patients in shock at the Emergency Department of Nancy? Main outcome: Describe the use of ultrasound in the initial diagnostic and therapeutic management of patients in shock at the Nancy Emergency Department Secondary outcome: Study the contribution of the use of different ultrasound techniques in the initial diagnostic and therapeutic management of patients depending on the type of shock state

Study Overview

• Status: Active, not recruiting
• Conditions: Shock
• Intervention / Treatment: Device: Use of ultrasound

• Study Type: Observational
• Enrollment (Estimated): 200

Contacts and Locations

Study Locations

• France
  • Nancy, France
    • CHRU

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Adult; Older Adult
• Accepts Healthy Volunteers: N/A

• Sampling Method: Non-Probability Sample

Study Population

Adults in shock at the Nancy ED

Description

Inclusion Criteria:

• Age ≥ 18 years old
• Shock (MAP < 65 mmHg + lactate ≥ 2 mmol/l)
• Admission to the Nancy ED between 01/01/2023 and 12/31/2023
• ICD-10 output coding: R57: shock, not elsewhere classified; R570: cardiogenic shock; R571: hypovolemic shock; R572: septic shock; R578: other shocks; R579: shock, unspecified; T794: traumatic shock; T782: anaphylactic shock, unspecified; or diagnosis of entry into intensive care including the word "shock"

Exclusion Criteria:

• Age < 18 years old
• Absence of shock
• No passage through the Nancy ED
• Patient whose initial treatment was carried out in another emergency department
• State of shock occurring after going to the emergency department

Study Plan

How is the study designed?

Number of groups / cohorts

2

Cohorts and Interventions

Group / Cohort	Intervention / Treatment
group receiving ultrasound	Device: Use of ultrasound; Use of ultrasound in the initial management of patients in shock
group not receiving ultrasound

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
rate of ultrasound use	use of different types of ultrasound or not for diagnostic and therapeutic purposes depending on the type of shock state	Day 0

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
rate of patients with care changes	changes in initial diagnostic and therapeutic management when an ultrasound technique is used compared to patients who did not benefit from it (duration of passage to ED and treatment, time until diagnosis, vascular filling rate, catecholamine utilization rate)	Day 0

Collaborators and Investigators

• Sponsor: Central Hospital, Nancy, France

Study record dates

Study Major Dates

• Study Start (Actual): January 1, 2023
• Primary Completion (Actual): January 1, 2023
• Study Completion (Estimated): October 31, 2025

Study Registration Dates

• First Submitted: August 19, 2024
• First Submitted That Met QC Criteria: August 23, 2024
• First Posted (Actual): August 27, 2024

Study Record Updates

• Last Update Posted (Actual): August 27, 2024
• Last Update Submitted That Met QC Criteria: August 23, 2024
• Last Verified: August 1, 2024

More Information

Terms related to this study

• Keywords: ultrasound; shock; emergency department
• Additional Relevant MeSH Terms: Pathologic Processes; Disease Attributes; Emergencies; Shock
• Other Study ID Numbers: 2024-A01851-46

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No